XML 65 R47.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF INVESTMENT (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Melt Pharmaceuticals, Inc. [Member]    
Schedule of Investments [Line Items]    
Cost Basis $ 24,207,000 $ 24,207,000
Share of Equity Method Losses (24,207,000) (24,207,000)
Net carrying value
Common Stock [Member] | Melt Pharmaceuticals, Inc. [Member]    
Schedule of Investments [Line Items]    
Cost Basis 5,810,000 5,810,000
Share of Equity Method Losses (5,810,000) (5,810,000)
Net carrying value
Common Stock [Member] | Surface Ophthalmics, Inc. [Member]    
Schedule of Investments [Line Items]    
Cost Basis 5,320,000 5,320,000
Share of Equity Method Losses (5,320,000) (5,320,000)
Net carrying value
Preferred Stock [Member] | Melt Pharmaceuticals, Inc. [Member]    
Schedule of Investments [Line Items]    
Cost Basis 18,397,000 18,397,000
Share of Equity Method Losses (18,397,000) (18,397,000)
Net carrying value